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Dromedary camels from Africa and Arabia are an estab-
lished source for zoonotic Middle East respiratory syndrome 
coronavirus (MERS-CoV) infection among humans. In Paki-
stan, we found specific neutralizing antibodies in samples 
from 39.5% of 565 dromedaries, documenting significant 
expansion of the enzootic range of MERS-CoV to Asia.
The Middle East respiratory syndrome coronavirus (MERS-CoV) is a zoonotic pathogen that causes se-
vere respiratory disease in humans. Dromedary camels 
(Camelus dromedarius), which have 1 hump on their backs, 
have been identified as an animal reservoir and source of 
human MERS-CoV infection (1). Reports document wide-
spread infection of these camels on the Arabian Peninsula 
and parts of Africa (2–4). Besides these regions, dromedar-
ies are also native to several countries in Asia. A study in 
Kazakhstan found no evidence for MERS-CoV infection 
in dromedaries (5). Absence of MERS-CoV infection in 
dromedary camels in Asia could mean a vulnerable ani-
mal reservoir at risk for de novo introduction by sporadic 
contact (e.g., by trade) with dromedaries from MERS-CoV 
endemic areas. Pakistan is 1 of 8 countries globally, and the 
only country outside Africa, that has a dromedary popu-
lation exceeding 1 million animals (FAOSTAT database; 
http://faostat3.fao.org). Because of the limited capacities 
for routine MERS-CoV surveillance and a considerable 
human population size in countries in northeastern Asia, 
targeted investigation of the MERS-CoV infection status is 
of interest for global public health agencies.
In this study, we examined dromedaries from Pakistan 
for exposure to MERS-CoV. We tested 565 serum samples, 
which we collected from 348 female and 217 male animals 
by using a convenience sampling strategy in 9 districts of 
Punjab, eastern Pakistan, during 2012–2015. The median 
age of the animals was 5 years.
The testing algorithm comprised 2 antibody detection 
methods (3,6). MERS-CoV IgG was detected by using a 
MERS-CoV camel antibody ELISA (EUROIMMUN, Lü-
beck, Germany). We tested all serum samples that exceed-
ed a cutoff of 0.4, validated in previous studies (3,6), by 
using a microneutralization (MN) test for confirmation (3). 
Only serum samples with neutralizing activity >1:80 were 
considered MERS-CoV antibody–positive.
A total of 315 (55.8%) of 565 camel serum samples 
exceeded the ELISA signal cutoff (Table). Of these, 223 
(39.5%) were confirmed by using MN. We identified 
MERS-CoV neutralizing antibodies in camels sampled in 
all study years and in nearly all regions except the district 
of Chiniot (Table). The rate of neutralizing antibody–posi-
tive camel samples ranged from 82.9% in Rahim Yar Khan 
to 24.1% in the Jhang district (Table).
By using a merged dataset comprising all regions, we 
correlated seropositivity to animal age and sex. Sex-de-
pendent differences suggested pronounced seropositivity in 
male animals, but differences were not significant (p>0.067; 
online Technical Appendix Table, https://wwwnc.cdc.gov/
EID/article/23/3/16-1285-Techapp1.pdf). Seropositivity in-
creased with age: samples from more than half (51.1%) of 
all animals >5 years of age and less than one third (29.2%) 
of animals <2 years of age tested positive (p<0.001; online 
Technical Appendix Table). These age-dependent differenc-
es are similar to those found in previous studies (6,7) and can 
be explained by long-lasting immune response or regular re-
exposure after initial MERS-CoV infection. The finding of 
antibodies in young camels born in Pakistan suggests ongo-
ing circulation of MERS-CoV in the country.
Bactrian camels (C. bactrianus), which have 2 humps 
on their backs, are also native to Central and East Asia. Stud-
ies of these camels in China and Mongolia, as well as drome-
dary and Bactrian camels in southern Kazakhstan, uniformly 
reported absence of MERS-CoV during 2014–2015 (5,8,9). 
However, dromedaries may become sources of infection 
for Bactrian camels that are susceptible to MERS-CoV and 
present in this vast geographic range. The possibility of 
cross-species transmission within the order of camelids has 
been documented by a study that found signs of MERS-CoV 
infection in alpacas (Vicugna pacos) that shared a barn with 
dromedaries in Qatar (10). The absence of MERS-CoV in 
camelid populations in northeastern parts of Asia (Mongolia, 
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Kazakhstan, and China) is compatible with the view that the 
spread of MERS-CoV from Africa into Asia may be a recent 
development. However, other explanations, including resis-
tance to infection by Bactrian camels, are possible. Studies 
of susceptibility should be conducted to clarify whether Bac-
trian camels in Asia could act as a naïve reservoir population 
in the future.
Based on MERS-CoV antibodies in dromedary cam-
els, our data suggest a risk for human exposure in Punjab, 
Pakistan, that is similar to risks in Africa and the Arabian 
Peninsula. Of note, Punjab shares a border with the state 
of Rajasthan in India, which harbors that country’s largest 
dromedary population. A similar risk for human exposure 
is likely for this part of India. However, findings of antibod-
ies against MERS-CoV in migrant workers from these ar-
eas should be interpreted with caution because these work-
ers often employed in Arabian countries. For Pakistan, our 
data largely exclude the scenario of a widely susceptible 
animal reservoir population in which de novo introduction 
of MERS-CoV could start an epizootic that could lead to 
spillover epidemics among humans.
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Table. Detection of Middle East respiratory syndrome coronavirus antibodies in dromedary camels from different districts of Punjab 
Province, Pakistan, 2012–2015* 












Detection rate, % 
(95% CI) 
Chiniot 2012, 2014 23 4 17.4 (5–38.8)  0 0 (0.0–14.8) 
Faisalabad 2012, 2013, 2015 66 45 68.2 (55.6–79.1)  32 48.5 (36.0–61.1) 
Jhang 2012, 2013, 2015 220 79 35.9 (29.6–42.6)  53 24.1 (18.6–30.3) 
Bhakkar 2012 88 51 57.9 (47–68.4)  36 40.9 (30.5–51.9) 
Layyah 2012 13 9 69.2 (38.6–90.9)  4 30.8 (9.1–61.4) 
Muzaffargarh 2012, 2013 40 26 65 (48.3–79.4)  15 37.5 (22.7–54.2) 
Bahawalpur 2015 29 26 89.7 (72.6–97.8)  21 72.4 (52.8–87.3) 
Lodhran 2014 51 42 82.4 (69.1–91.6)  33 64.7 (50.1–77.6) 
Rahim Yar Khan 2012 35 33 94.3 (80.8–99.3)  29 82.9 (66.4–93.4) 
Total  565 315 55.8 (51.5–59.9)  223 39.5 (35.4–43.6) 
*Serum samples were tested at a dilution of 1:100; MNT was done in a microtiter plate format in duplicate at a dilution of 1:80. ELISA ratio >0.4 and MN 
>1:80 were considered positive. MN, microneutralization. 
†Samples from all years, except the samples from 2012 and 2014 from Chiniot, were MN positive. 
 
